← Leaderboards
Arlene B Chapman
Emory University
$16,744,207
Attributed
$17,401,745
Total exposure
23
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$17,401,745 · 23
By mechanism
U01$11,124,174 · 2
M01$3,939,311 · 17
S10$1,284,000 · 1
R21$934,260 · 1
R56$100,000 · 1
R13$20,000 · 1
Top collaborators
- Donald L. Bliwise3 shared
- Jerome L. Abramson2 shared
- Katherine Macrae Dell1 shared
- Christopher A Flask1 shared
Most similar at Emory University
Same institution · by research overlap
- Andrew Thompson Taylor$8,870,738
- James C. Zimring$24,599,687
- Seema Rajnikant Patel$705,303
- Naziya P. Noorani$98,512
- W Charles O'Neill$5,219,082
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingBlood PressureClinical ResearchKidneyEnd Stage Renal FailureHypertensionHuman SubjectPolycystic KidneyPolycystic Kidney DiseasesKidney FailureKidney DiseasesClinical TrialsGlomerular Filtration RateUniversitiesResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseCystAutosomal Dominant TraitDisease ProgressionGeneticAfrican AmericanMeasurementPhenotypeRenal Function
Grant awards (67)
Whole-Room Calorimeter$1,284,000
S10 · FY2022 · OD · contact PI
MRI Risk Classification in Children and Young Adults with ADPKD$100,000
R56 · FY2022 · DK · contact PI
Limited Competition for the Continuation of the Consortium for Radiologic Imaging$60,000
U01 · FY2016 · DK · contact PI
Limited Competition for the Continuation of the Consortium for Radiologic Imaging$331,545
U01 · FY2015 · DK · contact PI
Limited Competition for the Continuation of the Corsortium for Radiologic Imagin$333,597
U01 · FY2014 · DK · contact PI
Limited Competition for the Continuation of the Corsortium for Radiologic Imagin$333,564
U01 · FY2013 · DK · contact PI
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria$585,579
U01 · FY2012 · DK · contact PI
Limited Competition for the Continuation of the Corsortium for Radiologic Imagin$331,545
U01 · FY2012 · DK · contact PI
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria$585,579
U01 · FY2011 · DK · contact PI
Limited Competition for the Continuation of the Corsortium for Radiologic Imagin$341,389
U01 · FY2011 · DK · contact PI
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria$585,579
U01 · FY2010 · DK · contact PI
The Early Collaborative Clinical Studies in PKD: The C*$313,329
U01 · FY2010 · DK · contact PI
Melatonin and Nighttime Blood Pressure in African Americans$191,813
R21 · FY2010 · AT · contact PI
Melatonin and Nighttime Blood Pressure in African Americans$509,947
R21 · FY2009 · AT · contact PI
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria$498,351
U01 · FY2009 · DK · contact PI
The Early Collaborative Clinical Studies in PKD: The C*$256,267
U01 · FY2009 · DK · contact PI
Melatonin and Nighttime Blood Pressure in African Americans$232,500
R21 · FY2009 · AT
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria$110,085
U01 · FY2009 · DK · contact PI
Polycystic Kidney Disease Clinical Trials Network$526,066
U01 · FY2008 · DK · contact PI
"The Early Collaborative Clinical Studies in PKD: The C*$337,438
U01 · FY2008 · DK · contact PI
"The Early Collaborative Clinical Studies in PKD: The C*$326,825
U01 · FY2007 · DK · contact PI
HALT PROGRESSION OF POLYCYSTIC KIDNEY DISEASE$41,637
M01 · FY2007 · RR · contact PI
PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)$31,968
M01 · FY2007 · RR · contact PI
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER$25,386
M01 · FY2007 · RR · contact PI
Polycystic Kidney Disease Clinical Trials Network$12,882
U01 · FY2007 · DK · contact PI
HALT-PKD$8,329
M01 · FY2007 · RR · contact PI
GERA-2 STUDY$6,447
M01 · FY2007 · RR · contact PI
THE ADPKD COHORT STUDY$1,343
M01 · FY2007 · RR · contact PI
Polycystic Kidney Disease Clinical Trials Network$400,000
U01 · FY2006 · DK · contact PI
"The Early Collaborative Clinical Studies in PKD: The C*$238,652
U01 · FY2006 · DK · contact PI
THE ADPKD COHORT STUDY$118,502
M01 · FY2006 · RR · contact PI
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER$88,009
M01 · FY2006 · RR · contact PI
Polycystic Kidney Disease Clinical Trials Network$52,931
U01 · FY2006 · DK · contact PI
ADPKD COHORT STUDY$12,148
M01 · FY2006 · RR · contact PI
CRISP STUDY$3,471
M01 · FY2006 · RR · contact PI
GERA-2 STUDY$1,240
M01 · FY2006 · RR · contact PI
PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)$991
M01 · FY2006 · RR · contact PI
ENDOTHELIAL FUNCTION IN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE$248
M01 · FY2006 · RR · contact PI
Polycystic Kidney Disease Clinical Trials Network$249,989
U01 · FY2005 · DK
THE ADPKD COHORT STUDY$190,770
M01 · FY2005 · RR
GERA-2 STUDY$159,720
M01 · FY2005 · RR
GERA-2 STUDY$118,409
M01 · FY2005 · RR
CRISP STUDY$88,149
M01 · FY2005 · RR
ADPKD COHORT STUDY$17,367
M01 · FY2005 · RR
Polycystic Kidney Disease Clinical Trials Network$589,985
U01 · FY2004 · DK
The ADPKD Cohort Study$548,508
M01 · FY2004 · RR
RENAL IMAGING AND PROGRESSION IN ADPKD$500,000
U01 · FY2004 · DK
GERA-2 Study$376,976
M01 · FY2004 · RR
CRISP Study$271,309
M01 · FY2004 · RR
RENAL IMAGING AND PROGRESSION IN ADPKD$181,841
U01 · FY2004 · DK
Genetic Epidemiology of Blood Pressure Response$69,970
M01 · FY2004 · RR
Polycystic Kidney Disease Clinical Trials Network$515,993
U01 · FY2003 · DK
RENAL IMAGING AND PROGRESSION IN ADPKD$500,000
U01 · FY2003 · DK
RENAL IMAGING AND PROGRESSION IN ADPKD$57,775
U01 · FY2003 · DK
RENAL IMAGING AND PROGRESSION IN ADPKD$33,617
U01 · FY2003 · DK
RENAL IMAGING AND PROGRESSION IN ADPKD$500,000
U01 · FY2002 · DK
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY COHORT STUDY$293,069
M01 · FY2002 · RR
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE TO DIURETICS$293,069
M01 · FY2002 · RR
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY COHORT STUDY$293,069
M01 · FY2002 · RR
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE TO DIURETICS$293,069
M01 · FY2002 · RR
Polycystic Kidney Disease Clinical Trials Network$250,000
U01 · FY2002 · DK
Polycystic Kidney Disease Clinical Trials Network$186,880
U01 · FY2002 · DK
Symposium for Molecular and Therapeutic Insights in PKD$20,000
R13 · FY2002 · DK
RENAL IMAGING AND PROGRESSION IN ADPKD$500,000
U01 · FY2001 · DK
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY COHORT STUDY$293,069
M01 · FY2001 · RR
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE TO DIURETICS$293,069
M01 · FY2001 · RR
RENAL IMAGING AND PROGRESSION IN ADPKD$496,891
U01 · FY2000 · DK